✦ LIBER ✦

Hand–foot syndrome in breast cancer patients receiving adjuvant chemotherapy

✍ Scribed by C. K. Lee; J. Lynch

Book ID: 109001987
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 44 KB
Volume: 37
Category: Article
ISSN: 1444-0903
DOI: 10.1111/j.1445-5994.2007.01332.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brain metastases in breast cancer patien

Brain metastases in breast cancer patients receiving adjuvant chemotherapy

✍ Alexander H. G. Paterson; Meera Agarwal; Alan Lees; John Hanson; Olga Szafran 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 352 KB 👁 3 views

Immunologic monitoring in breast cancer

Immunologic monitoring in breast cancer patients receiving postoperative adjuvant chemotherapy

✍ Lars-Erik Strender; Henric Blomgren; Björn Petrini; Jerzy Wasserman; Marianne Fo 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 English ⚖ 615 KB

Patterns of toxicity in older patients w

Patterns of toxicity in older patients with breast cancer receiving adjuvant chemotherapy

✍ Arti Hurria; Kelly Brogan; Katherine S. Panageas; Carol Pearce; Larry Norton; An 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 231 KB

Prognostic factors in node-positive oper

Prognostic factors in node-positive operable breast cancer patients receiving adjuvant chemotherapy

✍ E. Rakowsky; B. Klein; E. Kahan; E. Derazne; H. Lurie 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 874 KB

Endocrine profile in breast cancer patie

Endocrine profile in breast cancer patients receiving chemotherapy

✍ Rajeshwari R. Mehta; Craig W. Beattie; Tapas K. Das Gupta 📂 Article 📅 1991 🏛 Springer US 🌐 English ⚖ 792 KB

Carcinoembryonic antigen as a marker in

Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapy

✍ Hèndré C. Falkson; Geoffrey Falkson; M. Antonia Portugal; Johnnie J. Van Der Wat 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 535 KB

Serial plasma CEA levels were determined over a period of 1-3 years in 114 patients receiving adjuvant chemotherapy for T1, 2 or 3a N+ MO breast cancer. CEA values were correlated with clinical status, scintiscans, and other biochemical parameters. CEA values >2.5 ng/ml were considered abnormal. For